Gene mutation found in the bacterium behind the Black Death helped plague conquer the world, scientists say
Sign up for CNN's Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more.
One of the bleakest periods in medieval Europe was the plague pandemic known as the Black Death, which killed at least 25 million people in just five years. But the disease didn't stop there. The plague adapted to keep its hosts alive longer, so it could spread farther and keep infecting people for centuries, and researchers now say they've discovered how.
The disease is caused by the bacterium Yersinia pestis, which has been circulating among human populations for at least 5,000 years. The pathogen has fueled three major plague pandemics since the first century AD, and though its deadliest years appear to be behind us, plague hasn't disappeared. Cases still occur a few times a year in Asia, South America and the United States and more commonly in parts of Africa, according to the Cleveland Clinic, and can be treated with antibiotics.
Scientists are still searching for answers about how Y. pestis evolved and dispersed, but recent analysis of ancient and modern Y. pestis samples revealed how plague managed to persist among humans for hundreds of years after pandemic waves petered out. After an initial period of high infection rates and rapid mortality — killing infected people within three days — changes to just one gene in the bacterium produced new strains that were less deadly and more transmissible, according to research published Thursday in the journal Science.
Those weakened strains eventually went extinct; the dominant lineage of today's Y. pestis is the deadlier variety, the study authors reported. However, these findings about historic instances of Y. pestis adaptation could provide important clues to help scientists and physicians manage modern plague outbreaks.
Plague's most common form is bubonic plague, which causes painful swelling in lymph nodes and spreads among people through bites from fleas hitchhiking on infected rats. An outbreak of bubonic plague from 1347 to 1352 in Europe famously killed about 30% to 50% of the continent's population. But the earliest known bubonic plague outbreak — the Plague of Justinian — took hold in the Mediterranean Basin and lasted from AD 541 to AD 544. Another plague outbreak emerged in China in the 1850s and sparked a major epidemic in 1894. Scientists view modern plague cases as part of this third pandemic.
For the new study, scientists collected ancient samples of Y. pestis from human remains dating back to about 100 years after the appearance of the first and second plague pandemics, sampling remains from Denmark, Europe and Russia. After reconstructing the genomes of these plague strains, they compared them with older, ancient strains that dated back to the start of plague pandemics.
The researchers also examined more than 2,700 genomes of modern plague samples from Asia, Africa, and North and South America. One of the study coauthors, Jennifer Klunk, is a product scientist at Daciel Arbor Biosciences, a biotechnology company in Michigan that provided synthetically created molecules for the experiments, but there was no financial gain associated with the research.
The researchers found that their newly reconstructed genomes from 100 years into the first two plague pandemics had fewer copies of a gene called pla, which has been recognized for decades as one of the factors that made plague so deadly, according to the study's co-lead author Ravneet Sidhu, a doctoral student in the McMaster Ancient DNA Centre at McMaster University in Ontario, Canada.
Pla encodes an enzyme that interacts with host proteins, 'and one of the functions that it carries out is in breaking down blood clots,' Sidhu told CNN. This ability helps Y. pestis spread into the host's lymph nodes, where it replicates before attacking the rest of the body.
'Not every function of this gene is fully known,' Sidhu added. However, prior studies by other researchers linked pla to severity of illness caused by both bubonic and pneumonic plague — an airborne form of the disease that affects the lungs, she said.
While the reconstructed strains showed fewer copies of the pla gene, the scientists were still uncertain whether that would directly affect how deadly the disease could be. So they tested strains of reduced-pla bubonic plague on mice, and found that survival rates for this type of plague were 10 to 20 percent higher in those experiment subjects than in mice infected with Y. pestis that had a normal amount of the pla gene. It also took the reconstructed bubonic strain about two days longer to kill its hosts.
'The paper presents a strong argument that depletion, but not total loss, of Pla (the enzyme produced by the pla gene) is part of the evolution of the plague pathogen and may help explain the decline of plague in the second pandemic commonly known as the Black Death,' said Dr. Deborah Anderson, a professor of veterinary pathobiology at the University of Missouri's College of Veterinary Medicine. Anderson, who was not involved in the new research, investigates the virulence of plague, and these findings could shed light on transmission patterns in modern cases, she told CNN in an email.
'Our laboratory studies the flea-rodent cycle and we have collaborators who conduct field research in areas that experience annual or occasional plague outbreaks in the wild,' Anderson said.
'There are nearly 300 rodent species that can transmit Yersinia pestis, and today, burrowing rodents such as prairie dogs or ground squirrels are considered key animal hosts that experience outbreaks of disease,' she added. 'After reading this paper, we will pay closer attention to Pla in the future to see if there continues to be a role for its expression in driving the explosive outbreaks of plague in the animal populations.'
Mathematical models suggested how this might have played out in human populations centuries ago, leading to an 'epidemic burnout' about 100 years after a bubonic plague outbreak.
In a pandemic's early stages, infections were swift, and death came quickly for both rats and humans. Over time, as dense rat populations thinned out, selective pressures favored the emergence of a less deadly strain of Y. pestis, with fewer copies of the pla gene. Rat hosts infected with this new strain would have a little more time to carry the disease, potentially enabling them to infect more rats — and more people.
'They suggest a model that can be readily pursued in the laboratory that may help explain the spread of plague today in the wild,' Anderson said.
These weaker strains of the disease eventually sputtered out and went extinct. In the modern samples, the researchers found just three examples of strains with reduced pla genes, from Vietnam: one from a human subject and two from black rats (Rattus rattus).
'We've been able to do this really cool interdisciplinary study between the modern and ancient data and marry these things that have been happening throughout (the plague's) long evolutionary history,' Sidhu said. 'It could be interesting to see how future researchers continue to try and bridge that gap between the modern third pandemic and those first and second ancient pandemics, to see other similarities. Because there aren't a lot of ancient pathogens that we have as much data on, as we do for Yersinia pestis.'
One of the unusual features of plague pandemics is their persistence, and understanding how Y. pestis changed its infection patterns and survived over time could shed light on the adaptive patterns of modern pandemics such as Covid-19, she added.
'Even if we aren't experiencing it to the amount that we were in 2020 or 2021, the pathogen is in the background — still evolving and persisting.'
Mindy Weisberger is a science writer and media producer whose work has appeared in Live Science, Scientific American and How It Works magazine. She is the author of 'Rise of the Zombie Bugs: The Surprising Science of Parasitic Mind Control' (Hopkins Press).
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNN
34 minutes ago
- CNN
More measles exposures are happening at airports and tourist destinations. Here's what travelers need to know
Vaccines Children's health Aviation newsFacebookTweetLink Follow More than 1,100 measles cases have been reported in the United States this year, and the highly contagious virus has put people at risk while they wait in ERs and doctor's offices — but also at a Shakira concert in New Jersey, at a mall in Minnesota, at a Buc-ee's store in Texas and in airports and planes in several states. 'Travelers can catch measles in many travel settings including travel hubs like airports and train stations, on public transportation like airplanes and trains, at tourist attractions, and at large, crowded events,' the US Centers for Disease Control and Prevention said in a recently updated travel notice. 'Infected travelers can bring the disease back to their home communities where it can spread rapidly among people who are not immune.' It's a situation that may feel unfamiliar for US travelers. In 2000, measles was declared eliminated from the US due to highly effective and coordinated vaccination efforts. That year, only 85 cases were recorded, all of which were imported. But at least 1,157 measles cases have been reported this year, according to a CNN tally using data from state health departments. Only one other year since 2000 has had more cases: 2019, when there were 1,274. The vast majority of this year's cases have been part of an ongoing multistate outbreak centered in West Texas. The outbreak appears to be stabilizing, but there is growing concern around the risk of additional spread due to summer travel, said Lori Tremmel Freeman, chief executive officer for the National Association of County and City Health Officials. At the epicenter of the measles outbreak in Gaines County, 'that community has either become immune by contracting measles and developing immunity from the disease, or in some cases, they've gotten vaccinated,' Freeman said, but she added that 'there's a cautionary tale,' because of summer travel. 'Heavy travel is anticipated,' she warned. 'The travel spread could continue throughout the rest of the country as these groups become mobile and still carry the disease.' The CDC's health notice emphasizes that all international travelers should be fully vaccinated with the recommended two doses of the measles-mumps-rubella (MMR) vaccine and that infants ages 6 months to 11 months who are traveling should receive an extra dose. Dr. Peter Hotez, co-director of the Texas Children's Hospital Center for Vaccine Development, said this recommendation for infants was also given by the Texas Department of State Health Services in the 10 counties that have seen increased measles transmission during this year's outbreak. 'That means, then, that you're going to wind up giving three doses instead of two doses. Usually, you give one dose [to children between] 12 to 15 months, a second dose at 4 to 6 years [old]. Now, you're going to give three doses,' he said. But he emphasized that that this extra dose is still safe: 'The MMR vaccine is one of the safest vaccines we know.' Neither the Texas health department nor the CDC recommends the MMR vaccine for adults born before 1957, Hotez notes, riding on the assumption that measles exposure was common in the first half of the 20th century and that exposure would have led to enduring immunity. However, there are exceptions for health care workers serving a measles outbreak area, for whom two MMR doses are recommended regardless of birth year. Hotez highlights that vaccine recommendations may change as outbreaks continue, stressing the importance of staying aware of updates from local health officials. The MMR vaccine is not recommended for pregnant women, infants younger than 6 months and people who have severely weakened immune systems. Although the risk of exposure is generally low, people who can't be vaccinated should speak with their doctor about their individual risk tolerance, said Dr. Scott Roberts, associate medical director for infection prevention at the Yale School of Medicine. 'A lot of this depends on their access to therapeutics at their travel destination, like are they going to an area where immunoglobulins may be available?' Immunoglobulins, also known as antibodies, are naturally produced by the body as a part of immune responses. They play a crucial role in identifying and neutralizing foreign substances like bacteria and viruses and are specific to each pathogen. People who have a weakened immune system can get immunoglobulins, typically at a hospital or clinic, if they're exposed to measles. Historically, Roberts said, the most common source of US measles outbreaks has been non-immune US residents who traveled abroad, were exposed to the virus and then brought it back. Although some international travelers have brought measles into the US, this makes up a minority of cases. Although no country requires proof of MMR immunization for travel, Roberts advises travelers to 'double-check their immunity status before traveling internationally.' This immunity may involve a prior measles infection, birth before 1957, lab test results of measles immunity or written documentation of MMR immunization. Travelers should check their status at least 6 weeks before they leave, he said. Full immunity includes the two doses of MMR vaccine at least 28 days apart as well as the two weeks it takes to build up final immunity after the last dose. Two doses of the MMR vaccine are 97% effective against measles infection, so vaccinated travelers who suspect that they have been exposed to the virus shouldn't need to worry, Roberts said. Although that leaves a 3% chance of infection, symptoms are significantly lessened with the vaccine. If you are unvaccinated and suspect that you may have been exposed, Roberts says you should see a doctor as soon as possible. 'Depending on how soon you are after exposure, you can still do something,' he said. You may be able to get immunoglobulin or even the MMR vaccine to help lessen symptoms. Other than verifying immunity, Roberts advises typical travel guidance such as packing commonly used and prescribed medications, as well as keeping a list of hospitals or clinics at your destination and other first-aid supplies. When traveling internationally, Roberts recommends checking the country-specific travel health notices on the CDC website to stay aware of additional vaccinations and medications needed for certain destinations. Roberts advises travelers wash their hands frequently, avoid people who are sick when possible, stay in well-ventilated areas and wear masks if they are at high risk of severe illness, staying up to date with vaccinations, especially those who were unable to get vaccinated because of severe immunodeficiency. These practices don't just help prevent measles infection, they help curb infection from other circulating pathogens such as Covid-19 and the flu. Measles is one of the most contagious germs around. In one case 10 years ago, four travelers were infected by a person at the same airport gate. 'This highlights how contagious [measles] is,' Roberts said. 'Even airports and terminals are risky.' The ongoing measles outbreak is not to be taken lightly, Hotez said. 'In the 1980s, measles was the single leading killer of children globally. It [led to] 3 million deaths annually. Now, through the GAVI Vaccine Alliance and other programs, we've brought it down to around 100,000 deaths, but it's still a lot. And we're seeing what happens in West Texas. Ten percent, 20% of kids are being hospitalized, measles, pneumonia, neurologic injury. We've had over 90 hospitalizations so far in Texas and two measles deaths.'


CNN
36 minutes ago
- CNN
More measles exposures are happening at airports and tourist destinations. Here's what travelers need to know
Vaccines Children's health Aviation newsFacebookTweetLink Follow More than 1,100 measles cases have been reported in the United States this year, and the highly contagious virus has put people at risk while they wait in ERs and doctor's offices — but also at a Shakira concert in New Jersey, at a mall in Minnesota, at a Buc-ee's store in Texas and in airports and planes in several states. 'Travelers can catch measles in many travel settings including travel hubs like airports and train stations, on public transportation like airplanes and trains, at tourist attractions, and at large, crowded events,' the US Centers for Disease Control and Prevention said in a recently updated travel notice. 'Infected travelers can bring the disease back to their home communities where it can spread rapidly among people who are not immune.' It's a situation that may feel unfamiliar for US travelers. In 2000, measles was declared eliminated from the US due to highly effective and coordinated vaccination efforts. That year, only 85 cases were recorded, all of which were imported. But at least 1,157 measles cases have been reported this year, according to a CNN tally using data from state health departments. Only one other year since 2000 has had more cases: 2019, when there were 1,274. The vast majority of this year's cases have been part of an ongoing multistate outbreak centered in West Texas. The outbreak appears to be stabilizing, but there is growing concern around the risk of additional spread due to summer travel, said Lori Tremmel Freeman, chief executive officer for the National Association of County and City Health Officials. At the epicenter of the measles outbreak in Gaines County, 'that community has either become immune by contracting measles and developing immunity from the disease, or in some cases, they've gotten vaccinated,' Freeman said, but she added that 'there's a cautionary tale,' because of summer travel. 'Heavy travel is anticipated,' she warned. 'The travel spread could continue throughout the rest of the country as these groups become mobile and still carry the disease.' The CDC's health notice emphasizes that all international travelers should be fully vaccinated with the recommended two doses of the measles-mumps-rubella (MMR) vaccine and that infants ages 6 months to 11 months who are traveling should receive an extra dose. Dr. Peter Hotez, co-director of the Texas Children's Hospital Center for Vaccine Development, said this recommendation for infants was also given by the Texas Department of State Health Services in the 10 counties that have seen increased measles transmission during this year's outbreak. 'That means, then, that you're going to wind up giving three doses instead of two doses. Usually, you give one dose [to children between] 12 to 15 months, a second dose at 4 to 6 years [old]. Now, you're going to give three doses,' he said. But he emphasized that that this extra dose is still safe: 'The MMR vaccine is one of the safest vaccines we know.' Neither the Texas health department nor the CDC recommends the MMR vaccine for adults born before 1957, Hotez notes, riding on the assumption that measles exposure was common in the first half of the 20th century and that exposure would have led to enduring immunity. However, there are exceptions for health care workers serving a measles outbreak area, for whom two MMR doses are recommended regardless of birth year. Hotez highlights that vaccine recommendations may change as outbreaks continue, stressing the importance of staying aware of updates from local health officials. The MMR vaccine is not recommended for pregnant women, infants younger than 6 months and people who have severely weakened immune systems. Although the risk of exposure is generally low, people who can't be vaccinated should speak with their doctor about their individual risk tolerance, said Dr. Scott Roberts, associate medical director for infection prevention at the Yale School of Medicine. 'A lot of this depends on their access to therapeutics at their travel destination, like are they going to an area where immunoglobulins may be available?' Immunoglobulins, also known as antibodies, are naturally produced by the body as a part of immune responses. They play a crucial role in identifying and neutralizing foreign substances like bacteria and viruses and are specific to each pathogen. People who have a weakened immune system can get immunoglobulins, typically at a hospital or clinic, if they're exposed to measles. Historically, Roberts said, the most common source of US measles outbreaks has been non-immune US residents who traveled abroad, were exposed to the virus and then brought it back. Although some international travelers have brought measles into the US, this makes up a minority of cases. Although no country requires proof of MMR immunization for travel, Roberts advises travelers to 'double-check their immunity status before traveling internationally.' This immunity may involve a prior measles infection, birth before 1957, lab test results of measles immunity or written documentation of MMR immunization. Travelers should check their status at least 6 weeks before they leave, he said. Full immunity includes the two doses of MMR vaccine at least 28 days apart as well as the two weeks it takes to build up final immunity after the last dose. Two doses of the MMR vaccine are 97% effective against measles infection, so vaccinated travelers who suspect that they have been exposed to the virus shouldn't need to worry, Roberts said. Although that leaves a 3% chance of infection, symptoms are significantly lessened with the vaccine. If you are unvaccinated and suspect that you may have been exposed, Roberts says you should see a doctor as soon as possible. 'Depending on how soon you are after exposure, you can still do something,' he said. You may be able to get immunoglobulin or even the MMR vaccine to help lessen symptoms. Other than verifying immunity, Roberts advises typical travel guidance such as packing commonly used and prescribed medications, as well as keeping a list of hospitals or clinics at your destination and other first-aid supplies. When traveling internationally, Roberts recommends checking the country-specific travel health notices on the CDC website to stay aware of additional vaccinations and medications needed for certain destinations. Roberts advises travelers wash their hands frequently, avoid people who are sick when possible, stay in well-ventilated areas and wear masks if they are at high risk of severe illness, staying up to date with vaccinations, especially those who were unable to get vaccinated because of severe immunodeficiency. These practices don't just help prevent measles infection, they help curb infection from other circulating pathogens such as Covid-19 and the flu. Measles is one of the most contagious germs around. In one case 10 years ago, four travelers were infected by a person at the same airport gate. 'This highlights how contagious [measles] is,' Roberts said. 'Even airports and terminals are risky.' The ongoing measles outbreak is not to be taken lightly, Hotez said. 'In the 1980s, measles was the single leading killer of children globally. It [led to] 3 million deaths annually. Now, through the GAVI Vaccine Alliance and other programs, we've brought it down to around 100,000 deaths, but it's still a lot. And we're seeing what happens in West Texas. Ten percent, 20% of kids are being hospitalized, measles, pneumonia, neurologic injury. We've had over 90 hospitalizations so far in Texas and two measles deaths.'


Bloomberg
an hour ago
- Bloomberg
This Isn't How You ‘Restore Gold Standard' Science
In another attempt to concentrate power, President Donald Trump has signed an executive order to 'restore gold standard science' in federal research and policy. It sounds reasonable given the instances of bad or faked science being published, including high-profile papers on Alzheimer's drug development and one misleadingly claiming that hydroxychloroquine would cure Covid-19. In the last decade, scientists themselves have grown concerned about the large number of studies whose promising results couldn't be replicated. However, researchers dedicated to reforming their field say the president's plan isn't a solution. It's a way to give government officials the power to reject evidence they disagree with — without any accountability or transparency.